Vimarsana
Biggest News Aggregation in the World

Page 5 - Accelerating Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerating Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerating Access Today - Breaking & Trending Today

Utah's 4 Republicans easily keep their House seats - Vimarsana News

Utah's 4 Republicans easily keep their House seats

Utah's Republican incumbents solidified their control of the state's four congressional districts Tuesday, each leading their Democratic opponents by at least 40 points, early results show.

Source: ksl.com
FDA Grants $38 Million To Fund Rare Disease Research | MedTruth - Prescription Drug & Medical Device Safety - Vimarsana News

FDA Grants $38 Million To Fund Rare Disease Research | MedTruth - Prescription Drug & Medical Device Safety

The fund will back clinical trials, natural history studies, and regulatory science tools that will give the FDA a greater understanding of the ways that rare diseases can be treated.

FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS - Vimarsana News

FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS

SILVER SPRING, Md., Oct. 17, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38

Source: wtva.com
$38 million will fund rare disease research over four-year period - Vimarsana News

$38 million will fund rare disease research over four-year period

Research for rare diseases including ALS will be supported over the next four years by $38 million in FDA funding.

FDA Awards Above $38 Mln Worth Grants, Contracts In Rare Diseases - Vimarsana News

FDA Awards Above $38 Mln Worth Grants, Contracts In Rare Diseases

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has awarded 19 new grants and two new contracts totaling more than $38 million in funding mainly to develop medical products to treat